Abstract
Splenectomy is usually deferred for the first 12 months of onset of immune thrombocytopenia (ITP) because patients may have spontaneous remission. However, in patients with failed medical management, splenectomy is a valuable treatment option. This study aimed to evaluate the role of splenectomy in patients with persistent ITP with failed medical management at a tertiary care center. A retrospective review of records of all patients who underwent splenectomy for ITP between January 2010 and December 2019 was done. We identified the patients with primary ITP refractory to medical management who were referred from hematology to our department for splenectomy and their clinical course was evaluated. Most of the patients were females (14/20, 70%), and the mean age of patients in our series was 33.7 ± 11.1 years. Skin petechiae and mucosal bleeding were the most common presenting symptoms. Mean pre-operative platelet count was 20,079 ± 11,644/μL. After a trial of medical management for a mean duration of 6.7 ± 3.6 months, patients were planned for splenectomy. All patients improved symptomatically after surgery. A significant increase in platelet count was observed (mean: 80,290 ± 75,327/μL). Splenectomy (either open or laparoscopic approach) is a safe and very good option in patients with new onset and persistent ITP refractory to medical management with favorable outcomes.
Similar content being viewed by others
Data Availability
Not applicable.
Code Availability
Not applicable.
References
Kaznelson P (1916) Verschwinden der hamorrhagischen diathese bei einem falle von essentieller thrombopenie (frank) nach milzexstiparation : Splenogene thrombolytische purpura. Wien Klin Wochenschr 29:1451
Chaturvedi S, Arnold DM, McCrae KR (2018) Splenectomy for immune thrombocytopenia: down but not out. Blood 131:1172–1182. https://doi.org/10.1182/blood-2017-09-742353
Neunert C, Terrell DR, Arnold DM et al (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3:3829–3866. https://doi.org/10.1182/bloodadvances.2019000966
Provan D, Arnold DM, Bussel JB et al (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3:3780–3817. https://doi.org/10.1182/bloodadvances.2019000812
Rodeghiero F, Michel M, Gernsheimer T et al (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 121:2596–2606. https://doi.org/10.1182/blood-2012-07-442392
British Committee for Standards in Haematology General Haematology Task Force (2003) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120:574–596. https://doi.org/10.1046/j.1365-2141.2003.04131.x
Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549–2554. https://doi.org/10.1182/blood.V97.9.2549
Akwari OE, Itani KM, Coleman RE, Rosse WF (1987) Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg 206:529–541
Cola B, Tonielli E, Sacco S et al (1986) Surgical treatment of chronic idiopathic thrombocytopenic purpura: results in 107 cases. Int Surg 71:195–198
Harold KL, Schlinkert RT, Mann DK et al (1999) Long-term results of laparoscopic splenectomy for immune thrombocytopenic purpura. Mayo Clin Proc 74:37–39. https://doi.org/10.4065/74.1.37
Katkhouda N, Hurwitz MB, Rivera RT et al (1998) Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 228:568–578. https://doi.org/10.1097/00000658-199810000-00013
Watson DI, Coventry BJ, Chin T et al (1997) Laparoscopic versus open splenectomy for immune thrombocytopenic purpura. Surgery 121:18–22. https://doi.org/10.1016/S0039-6060(97)90177-X
Neylon AJ, Saunders PWG, Howard MR et al (2003) Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122:966–974. https://doi.org/10.1046/j.1365-2141.2003.04547.x
Thai L-H, Mahévas M, Roudot-Thoraval F et al (2016) Long-term complications of splenectomy in adult immune thrombocytopenia. Medicine (Baltimore) 95:e5098. https://doi.org/10.1097/MD.0000000000005098
Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood 64:1179–1183. https://doi.org/10.1182/blood.V64.6.1179.1179
Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104:2623–2634. https://doi.org/10.1182/blood-2004-03-1168
Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol 81:312–319. https://doi.org/10.1007/s00277-002-0461-8
Duperier T, Brody F, Felsher J et al (2004) Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura. Arch Surg 139:61–66. https://doi.org/10.1001/archsurg.139.1.61
Mintz SJ, Petersen SR, Cheson B et al (1981) Splenectomy for immune thrombocytopenic purpura. Arch Surg 116:645–650. https://doi.org/10.1001/archsurg.1981.01380170121022
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chaturvedi, A., Baig, K., Rathore, Y. et al. Splenectomy for Acute or Persistent Immune Thrombocytopenia: an Overkill or a Necessity. Indian J Surg 84, 1205–1210 (2022). https://doi.org/10.1007/s12262-021-03206-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-021-03206-1